EWTX R&D Expenses
Edgewise Therapeutics Inc · R&D Expenses
EWTX R&D Expenses
Latest reported$171.27Mperiod ending
EWTX TTM R&D Expenses ($14.98M → $171.27M)
TTM R&D Expenses
High-resolution chart · PNG
EWTX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 171,273,000 | |
| 157,283,000 | |
| 151,389,000 | |
| 144,165,000 | |
| 138,907,000 | |
| 136,029,000 | |
| 126,966,000 | |
| 118,280,000 | |
| 109,844,000 | |
| 98,723,000 | |
| 90,905,000 | |
| 79,833,000 | |
| 69,941,000 | |
| 62,784,000 | |
| 54,032,000 | |
| 46,508,000 | |
| 42,494,000 | |
| 37,953,000 | |
| 32,189,000 | |
| 28,240,000 | |
| 21,598,000 | |
| 17,376,000 | |
| 14,983,000 |